Focus and Scope

Focusing of Medisains journal are publishing the health and medical research, including medicine, surgery, gynecology and obstetrics, psychiatry, pediatrics, microbiology, pathology and laboratory medicine, radiology, medical education, public and community health, and nursing care.

 

Section Policies

Editorial

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Original Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Innovation

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case Report

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Brief Images

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Technique

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Medisains publishes about 15-20% of submitted papers each year. The publication process from submission to publication may take a maximum of three months depending on how complaint authors are to policies, the editorial team and reviewers. The entire publication process can be seen here. 

Manuscripts are selected based on the strength of the paper compared with other papers under review. We send the reviewers’ comments to authors whether or not we accept the article. On occasion, we reject an article but invite a resubmission that addresses specific concerns of the editors. The procedures for manuscript review include:

1. With one week of receipt of a manuscript, one of the Editorial Board (EB) members will review it in reference to 

  • conformity with the Journal’s ‘’Author Guidelines’’,
  • relevance of the article to the readers of the Medisains Journal,
  • clarity of presentation, and
  •  its scientific and ethical acceptability. (declaration of conflict of interest can be found here)

The EB has three options: accept manuscripts for external review, return it to author for revision, or reject it. A manuscript not accepted by a board member is blindly by another board member. If not accepted by both, the manuscript is rejected by the EB. Decision will be made by the suggestion of a third EB member if the decisions of first two do not concur.

2. Once accepted for external review, the EB sent the manuscript to exsternal reviewers with appropriate expertise. The peer review process of Medisains Journal follows as it stands now follows a Double blind review where both authors and reviewers identities are kept anonymous. Peer review comments should be objective and constructive without being hostile/too negative to the author(s) (COPE guideline), in reviewing articles, reviewers must also comply with the following journal review guidelines. Reviewers will be asked to review and return manuscripts within 2 weeks of their receipt. Reviewers have few options; accept, accept with major revision, accept with minor revision, or reject.

3. Manuscripts accepted with revision will be returned to the first author. Author(s) will be given four weeks to respond to external reviewers’ comments, make necessary changes, and return their manuscript to the EB.

4.  Manuscripts with minor revisions will be cleared by the EB and accepted for publication. Those with major revisions will be returned to external reviewers and follow the procedures as outlined for the initial review.

5. When the manuscript is accepted, we notify authors when they can expect to receive galley proofs. Authors are expected to examine proofs within 48 hours of receiving them.

6. All accepted manuscripts are subject to copy editing to improve clarity and achieve consistency of style and formatting of journal content. Authors will have the opportunity to approve revisions made during the copy editing process.

7.The EB welcomes comments from Journal readers on the above procedures.

 

Publication Frequency

Medisains published three times a year (April, August and December)

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.

Medisains stores back issues and current articles following LOCKSS idea of keeping lots of copies of our items on several servers to keep them safe. Archives are stored in Universitas Muhammadiyah Purwokerto repository server, the university's Local Content Collection and all of them are digitally submitted to Indonesian National Library's Indonesia OneSearch and periodically harvested by OCLC WorldCat. Published issues are also sent to LIPI (Lembaga Ilmu Pengetahuan Indonesia) the Indonesian Institute of Sciences to be retained in its repository. Medisains also implementing PKP Private LOCKSS Network (PLN).

 

Scientific Statement

The Medisains Journal is a scientific journal that publishes research results in the field of health. Medisains apply publication management and published articles must go through a review and editing process. articles received depend on the decision of the editorial board meeting.

 

Copyright Notice and Licensing

Please find the rights and licenses in Medisains.

1.   Copyright

All published papers become the permanent property of Medisains journal. Copyrights of all published materials are owned by Medisains journal. Permission must be obtained from Medisains journal for any commercial use of materials. Every author should sign the copyright transfer agreement forms.

2.    License

The non-commercial use of the article will be governed by the Creative Commons Attribution license as currently displayed on Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

3.    Author’s Warranties

The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).

4.    User Rights

Medisains spirit is to disseminate articles published are as free as possible. Under the Creative Commons license, Medisains permits users to copy, distribute, display, and perform the work for non-commercial purposes only. Users will also need to attribute authors and Medisains on distributing works in the journal.

5.    Rights of Authors

Authors retain the following rights:

  • The right to use the substance of the article in future own works, including lectures and books,
  • The right to reproduce the article for own purposes, provided the copies are not offered for sale,
  • The right to self-archive the article,
  • The right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the article's published version (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
6.    Co-Authorship

If the article was jointly prepared by other authors, the signatory of this form warrants that he/she has been authorized by all co-authors to sign this agreement on their behalf, and agrees to inform his/her co-authors of the terms of this agreement.

7.    Termination

This agreement can be terminated by the author or Medisains upon two months’ notice where the other party has materially breached this agreement and failed to remedy such breach within a month of being given the terminating party’s notice requesting such breach to be remedied. No breach or violation of this agreement will cause this agreement or any license granted in it to terminate automatically or affect the definition of Medisains. 

8.    Royalties

This agreement entitles the author to no royalties or other fees. To such extent as legally permissible, the author waives his or her right to collect royalties relative to the article in respect of any use of the article by Medisains or its sublicensee.

9.    Miscellaneous

Medisains will publish the article (or have it published) in the journal if the article’s editorial process is successfully completed and Medisains or its sublicensee has become obligated to have the article published. Medisains may conform the article to a style of punctuation, spelling, capitalization, referencing and usage that it deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers.

 

Publication Ethics Statement

Medisains is a peer-reviewed journal. This statement clarifies the ethical behavior of all parties involved in the act of publishing an article in this journal, including the author, the chief editor, the Editorial Board, the peer-reviewer­­­­­ and the publisher (LPIP Universitas Muhammadiyah Purwokerto). This statement is based on COPE’s Code of Conduct and Best Practice Guidelines for Journal Editors (see below)

Ethical Guideline for Journal Publication
The publication of an article in a peer-reviewed Medisains journal is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is, therefore, important to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, the publisher and the society.  

Publisher and Editor

Lembaga Publikasi Ilmiah dan Penerbitan Universitas Mumahmmadiyah Purwokerto (LPIP UMP) as publisher of Medisains takes its duties of guardianship over all stages of publishing extremely seriously and we recognize our ethical and other responsibilities. We are committed to ensuring that advertising, reprint or other commercial revenue has no impact or influence on editorial decisions. In addition, the Universitas Muhammadiyah Purwokerto and Editorial Board will assist in communications with other journals and/or publishers where this is useful and necessary.

  • Publication decisions: The editor of the Medisains journal is responsible for deciding which of the articles submitted to the journal should be published. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editors may confer with other editors or reviewers in making this decision.
  • Fair play: An editor at any time evaluates manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.
  • Confidentiality: The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
  • Disclosure and conflicts of interest: Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.

Reviewers

  • Contribution to Editorial Decisions: Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper.
  • Promptness: Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.
  • Confidentiality: Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.
  • Standards of Objectivity: Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.
  • Acknowledgment of Sources: Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
  • Disclosure and Conflict of Interest: Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Authors

  • Reporting standards: Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.
  • Data Access and Retention: Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.
  • Originality and Plagiarism: The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.
  • Multiple, Redundant or Concurrent Publication: An author should not, in general, publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable.
  • Acknowledgment of Sources: Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.
  • Authorship of the Paper: Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
  • Disclosure and Conflicts of Interest: All authors should disclose in their manuscript any financial or other substantive conflicts of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.
  • Fundamental errors in published works: When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

 

Plagiarism and Retraction Policy

Medisains Editorial board recognizes that plagiarism is not acceptable and therefore establishes the following policy stating specific actions (penalties) when plagiarism is identified in an article that is submitted for publication in Medisains. Medisains  will use ithenticate originality checking software as our tool in detecting similarities of texts in articles.

Definition:

Plagiarism involves the "use or close imitation of the language and thoughts of another author and the representation of them as one's own original work."

Policy:

Papers must be original, unpublished, and not pending publication elsewhere. Any material taken verbatim from another source needs to be clearly identified as different from the present original text by (1) indentation, (2) use of quotation marks, and (3) identification of the source.

Any text of an amount exceeding fair use standards (herein defined as more than two or three sentences or the equivalent thereof) or any graphic material reproduced from another source requires permission from the copyright holder and, if feasible, the original author(s) and also requires identification of the source; e.g., previous publication.

When plagiarism is identified, the Editor in Chief responsible for the review of this paper and will agree on measures according to the extent of plagiarism detected in the paper in agreement with the following guidelines:

Level of Plagiarism

  • Minor: A short section of another article is plagiarized without any significant data or idea taken from the other paper

Action: A warning is given to the authors and a request to change the text and properly cite the original article is made

  • Intermediate: A significant portion of a paper is plagiarized without proper citation to the original paper

Action: The submitted article is rejected and the authors are forbidden to submit further articles for one year

  • Severe: A significant portion of a paper is plagiarized that involves reproducing original results or ideas presented in another publication

Action: The paper is rejected and the authors are forbidden to submit further articles for five years.

It is understood that all authors are responsible for the content of their submitted paper as they all read and understand Medisains Copyright and Licensing Terms. If a penalty is imposed for plagiarism, all authors will be subject to the same penalty.

If the second case of plagiarism by the same author(s) is identified, a decision on the measures to be enforced will be made by the Editorial board (Editor-in-Chief, and Editorial members) with the Chair of the Editor in Chief. The author(s) might be forbidden to submit further articles forever.

This policy applies also to material reproduced from another publication by the same author(s). If an author uses text or figures that have previously been published, the corresponding paragraphs or figures should be identified and the previous publication referenced. It is understood that in the case of a review paper or a paper of a tutorial nature much of the material was previously published.

The author should identify the source of the previously published material and obtain permission from the original author and the publisher. If an author submits a manuscript to Medisains with significant overlap with a manuscript submitted to another journal simultaneously, and this overlap is discovered during the review process or after the publications of both papers, the editor of the other journal is notified and the case is treated as a severe plagiarism case. Significant overlap means the use of identical or almost identical figures and identical or slightly modified text for one-half or more of the paper. For self-plagiarism of less than one-half of the paper but more than one tenth of the paper, the case shall be treated as intermediate plagiarism. If self-plagiarism is confined to the methods section, the case shall be considered as minor plagiarism.

If an author uses some of his previously published material to clarify the presentation of new results, the previously published material shall be identified and the difference to the present publication shall be mentioned. Permission to republish must be obtained from the copyright holder. In the case of a manuscript that was originally published in conference proceedings and then is submitted for publication in Medisains either in identical or in expanded form, the authors must identify the name of the conference proceedings and the date of the publication and obtain permission to republish from the copyright holder. The editor may decide not to accept this paper for publication.

However, an author shall be permitted to use material from an unpublished presentation, including visual displays, in a subsequent journal publication. In the case of a publication being submitted, that was originally published in another language, the title, date, and journal of the original publication must be identified by the authors, and the copyright must be obtained. The editor may accept such a translated publication to bring it to the attention of a wider audience. The editor may select a specific paper that had been published (e.g. a “historic” paper) for republication in order to provide a better perspective of a series of papers published in one issue of Medisains. This republication shall be clearly identified as such and the date and journal of the original publication shall be given, and the permission of the author(s) and the publisher shall be obtained.

The Medisains layout editor for the Journal is responsible for maintaining the list of authors subjected to penalties and will check that no authors of a submitted paper are on this list. If a banned author is identified, the layout editor will inform the Editor-in-Chief who will take appropriate measures. This policy will be posted on the website with the instructions for submitting a manuscript, and a copy will be sent to the authors with the confirmation email upon initial receipt of their original manuscript.

Retraction and/or Corrections

Authors are discouraged from withdrawing submitted manuscripts after it is in the publication process (review, copyedit, layout, etc.,). During the time, Medisains had spent valuable resources besides time spent in the process. Should under any circumstances that the author(s) still request for a withdrawal, author(s) should pay back every effort put into the manuscript processes at an amount of US $100. Paid upon official request from the author(s) in an email sent to Medisains editor using the same email address used in correspondence.

Medisains editors shall consider retracting a publication if:

  • they have clear evidence that the findings are unreliable, either as a result of misconduct (e.g. data fabri.cation) or honest error (e.g. miscalculation or experimental error)
  • the findings have previously been published elsewhere without proper crossreferencing, permission or justification (i.e. cases of redundant publication)
  • it constitutes plagiarism
  • it reports unethical research  

Medisains editors shall consider issuing an expression of concern if:

  • they receive inconclusive evidence of research or publication misconduct by the authors
  • there is evidence that the findings are unreliable but the authors’ institution will not investigate the case
  • they believe that an investigation into alleged misconduct related to the publication either has not been, or would not be, fair and impartial or conclusive
  • an investigation is underway but a judgement will not be available for a considerable time

Medisains editors shall consider issuing a correction if:

  • a small portion of an otherwise reliable publication proves to be misleading (especially because of honest error)
  • the author/contributor list is incorrect (i.e. a deserving author has been omitted or somebody who does not meet authorship criteria has been included)

The mechanism follows the guidelines from Committee on Publication Ethics (COPE) which can be accessed at here